Home › Funds › GordonMD Global Investments LP › EDIT
GordonMD Global Investments LP position in EDIT
EDITAS MEDICINE INC · Health Care
GordonMD Global Investments LP reported holding 3,127,000 shares of EDIT (EDITAS MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 4.83% of its reported portfolio and ranking #10 among its reported holdings. GordonMD Global Investments LP has disclosed EDIT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GordonMD Global Investments LP's EDIT position evolved
GordonMD Global Investments LP first disclosed a stake in EDIT in Q2 2026 at 3,127,000 shares (US$10.1M). Across 2 filings, GordonMD Global Investments LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,127,000 shares valued at US$8.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.13M | $10.13M | New |
| Q3 2026 | 3.13M | $8.04M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EDIT and 13F data
EDIT (EDITAS MEDICINE INC) is a Health Care company. 35 other funds we track also report a position in EDIT — the largest reported positions include Commodore Capital LP (US$28.8M), TCG Crossover Management, LLC (US$28.6M), ADAR1 Capital Management, LLC (US$22.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EDIT
- Commodore Capital LP 8.89M sh · $28.80M · Q2 2026
- TCG Crossover Management, LLC 11.11M sh · $28.56M · Q3 2026
- ADAR1 Capital Management, LLC 8.89M sh · $22.84M · Q3 2026
- Paradigm Biocapital Advisors LP 7.58M sh · $19.47M · Q3 2026
- Opaleye Management Inc. 3.86M sh · $12.51M · Q2 2026
- Vivo Capital, LLC 3.56M sh · $9.14M · Q3 2026
- Logos Global Management LP 2.22M sh · $5.71M · Q3 2026
- Seven Fleet Capital Management LP 1.33M sh · $4.31M · Q2 2026
- HighVista Strategies LLC 1.11M sh · $2.85M · Q3 2026
More on GordonMD Global Investments LP
FAQ
How long has GordonMD Global Investments LP held EDIT?
GordonMD Global Investments LP has disclosed EDIT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is GordonMD Global Investments LP's current position in EDIT?
As of Q3 2026, GordonMD Global Investments LP holds 3.13M shares of EDIT (EDITAS MEDICINE INC), valued at $8.04M, representing 4.83% of its reported portfolio and ranking #10.
Has GordonMD Global Investments LP been buying or selling EDIT?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP held unchanged its position in EDIT.
Which other funds hold EDIT?
Other major institutional holders of EDIT include Commodore Capital LP, TCG Crossover Management, LLC, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.